| Year |
Citation |
Score |
| 2024 |
Ha A, Khoo A, Ignatchenko V, Khan S, Waas M, Vesprini D, Liu SK, Nyalwidhe JO, Semmes OJ, Boutros PC, Kislinger T. Comprehensive Prostate Fluid-Based Spectral Libraries for Enhanced Protein Detection in Urine. Journal of Proteome Research. PMID 38580319 DOI: 10.1021/acs.jproteome.4c00009 |
0.695 |
|
| 2024 |
Waas M, Khoo A, Tharmapalan P, McCloskey CW, Govindarajan M, Zhang B, Khan S, Waterhouse PD, Khokha R, Kislinger T. Droplet-based proteomics reveals CD36 as a marker for progenitors in mammary basal epithelium. Cell Reports Methods. 100741. PMID 38569541 DOI: 10.1016/j.crmeth.2024.100741 |
0.687 |
|
| 2024 |
Khan S, Zuccato JA, Ignatchenko V, Singh O, Govindarajan M, Waas M, Mejia-Guerrero S, Gao A, Zadeh G, Kislinger T. Organelle resolved proteomics uncovers PLA2R1 as a novel cell surface marker required for chordoma growth. Acta Neuropathologica Communications. 12: 39. PMID 38454495 DOI: 10.1186/s40478-024-01751-w |
0.72 |
|
| 2023 |
Kim H, Aliar K, Tharmapalan P, McCloskey CW, Kuttanamkuzhi A, Grünwald BT, Palomero L, Mahendralingam MJ, Waas M, Mer AS, Elliott MJ, Zhang B, Al-Zahrani KN, Langille ER, Parsons M, ... ... Kislinger T, et al. Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages. Cell Reports. 42: 113382. PMID 37883228 DOI: 10.1016/j.celrep.2023.113382 |
0.644 |
|
| 2023 |
Kim H, Aliar K, Tharmapalan P, McCloskey CW, Kuttanamkuzhi A, Grünwald BT, Palomero L, Mahendralingam MJ, Waas M, Mer AS, Elliott MJ, Zhang B, Al-Zahrani KN, Langille ER, Parsons M, ... ... Kislinger T, et al. Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages. Cell Reports. 42: 113256. PMID 37847590 DOI: 10.1016/j.celrep.2023.113256 |
0.679 |
|
| 2023 |
Khoo A, Govindarajan M, Qiu Z, Liu LY, Ignatchenko V, Waas M, Macklin A, Keszei A, Main BP, Yang L, Lance RS, Downes MR, Semmes OJ, Vesprini D, Liu SK, ... ... Kislinger T, et al. Prostate Cancer Reshapes the Secreted and Extracellular Vesicle Urinary Proteomes. Biorxiv : the Preprint Server For Biology. PMID 37546794 DOI: 10.1101/2023.07.23.550214 |
0.701 |
|
| 2020 |
Govindarajan M, Wohlmuth C, Waas M, Bernardini MQ, Kislinger T. High-throughput approaches for precision medicine in high-grade serous ovarian cancer. Journal of Hematology & Oncology. 13: 134. PMID 33036656 DOI: 10.1186/s13045-020-00971-6 |
0.687 |
|
| 2020 |
Waas M, Kislinger T. Addressing Cellular Heterogeneity in Cancer through Precision Proteomics. Journal of Proteome Research. PMID 32697918 DOI: 10.1021/Acs.Jproteome.0C00338 |
0.726 |
|
| 2020 |
Otto JJ, Correll VL, Engstroem HA, Hitefield NL, Main BP, Albracht B, Johnson-Pais T, Yang LF, Liss M, Boutros PC, Kislinger T, Leach RJ, Semmes OJ, Nyalwidhe JO. Targeted Mass Spectrometry of a Clinically Relevant PSA Variant from Post-DRE Urines for Quantitation and Genotype Determination. Proteomics. Clinical Applications. e2000012. PMID 32614141 DOI: 10.1002/Prca.202000012 |
0.346 |
|
| 2020 |
Macklin A, Khan S, Kislinger T. Recent advances in mass spectrometry based clinical proteomics: applications to cancer research. Clinical Proteomics. 17: 17. PMID 32489335 DOI: 10.1186/S12014-020-09283-W |
0.384 |
|
| 2019 |
Houlahan KE, Shiah YJ, Gusev A, Yuan J, Ahmed M, Shetty A, Ramanand SG, Yao CQ, Bell C, O'Connor E, Huang V, Fraser M, Heisler LE, Livingstone J, Yamaguchi TN, ... ... Kislinger T, et al. Genome-wide germline correlates of the epigenetic landscape of prostate cancer. Nature Medicine. PMID 31591588 DOI: 10.1038/S41591-019-0579-Z |
0.33 |
|
| 2019 |
Sinha A, Hussain A, Ignatchenko V, Ignatchenko A, Tang KH, Ho VWH, Neel BG, Clarke B, Bernardini MQ, Ailles L, Kislinger T. N-Glycoproteomics of Patient-Derived Xenografts: A Strategy to Discover Tumor-Associated Proteins in High-Grade Serous Ovarian Cancer. Cell Systems. PMID 30981729 DOI: 10.1016/J.Cels.2019.03.011 |
0.342 |
|
| 2019 |
Sinha A, Huang V, Livingstone J, Wang J, Fox NS, Kurganovs N, Ignatchenko V, Fritsch K, Donmez N, Heisler LE, Shiah YJ, Yao CQ, Alfaro JA, Volik S, Lapuk A, ... ... Kislinger T, et al. The Proteogenomic Landscape of Curable Prostate Cancer. Cancer Cell. 35: 414-427.e6. PMID 30889379 DOI: 10.1016/J.Ccell.2019.02.005 |
0.363 |
|
| 2019 |
Vora P, Venugopal C, Chokshi C, Qazi M, Tatari N, Brown K, Yelle N, Adams J, Tieu D, Seyfrid M, Singh M, Savage N, Subapanditha M, Bakhshinyan D, Kuhlmann L, ... Kislinger T, et al. Abstract 570: A glioblastoma translational pipeline: discovery of novel tumor antigens that drive GBM recurrence Cancer Research. 79: 570-570. DOI: 10.1158/1538-7445.Am2019-570 |
0.348 |
|
| 2018 |
Sonzogni O, Haynes J, Seifried LA, Kamel YM, Huang K, BeGora MD, Yeung FA, Robert-Tissot C, Heng YJ, Yuan X, Wulf GM, Kron KJ, Wagenblast E, Lupien M, Kislinger T, et al. Reporters to mark and eliminate basal or luminal epithelial cells in culture and in vivo. Plos Biology. 16: e2004049. PMID 29924804 DOI: 10.1371/Journal.Pbio.2004049 |
0.326 |
|
| 2018 |
Casey AE, Sinha A, Singhania R, Livingstone J, Waterhouse P, Tharmapalan P, Cruickshank J, Shehata M, Drysdale E, Fang H, Kim H, Isserlin R, Bailey S, Medina T, Deblois G, ... ... Kislinger T, et al. Mammary molecular portraits reveal lineage-specific features and progenitor cell vulnerabilities. The Journal of Cell Biology. PMID 29921600 DOI: 10.1083/Jcb.201804042 |
0.366 |
|
| 2018 |
Principe S, Mejia-Guerrero S, Ignatchenko V, Sinha A, Ignatchenko A, Shi W, Pereira K, Su S, Huang SH, O'Sullivan B, Xu W, Goldstein D, Weinreb I, Ailles L, Liu FF, ... Kislinger T, et al. Proteomic Analysis of Cancer Associated Fibroblasts Reveal a Paracrine Role for MFAP5 in Human Oral Tongue Squamous Cell Carcinoma. Journal of Proteome Research. PMID 29681158 DOI: 10.1021/Acs.Jproteome.7B00925 |
0.448 |
|
| 2018 |
Kuhlmann L, Cummins E, Samudio I, Kislinger T. Cell-surface proteomics for the identification of novel therapeutic targets in cancer. Expert Review of Proteomics. 1-17. PMID 29343144 DOI: 10.1080/14789450.2018.1429924 |
0.4 |
|
| 2018 |
Sinha A, Principe S, Alfaro J, Ignatchenko A, Ignatchenko V, Kislinger T. Proteomic Profiling of Secreted Proteins, Exosomes, and Microvesicles in Cell Culture Conditioned Media. Methods in Molecular Biology (Clifton, N.J.). 1722: 91-102. PMID 29264800 DOI: 10.1007/978-1-4939-7553-2_6 |
0.401 |
|
| 2017 |
Emirbayer PE, Sinha A, Ignatchenko V, Hoyer S, Dörrie J, Schaft N, Pischetsrieder M, Kislinger T. Proteomic response of human umbilical vein endothelial cells to histamine stimulation. Proteomics. PMID 28921918 DOI: 10.1002/Pmic.201700116 |
0.315 |
|
| 2017 |
Cogger KF, Sinha A, Sarangi F, McGaugh EC, Saunders D, Dorrell C, Mejia-Guerrero S, Aghazadeh Y, Rourke JL, Screaton RA, Grompe M, Streeter PR, Powers AC, Brissova M, Kislinger T, et al. Glycoprotein 2 is a specific cell surface marker of human pancreatic progenitors. Nature Communications. 8: 331. PMID 28835709 DOI: 10.1038/S41467-017-00561-0 |
0.34 |
|
| 2017 |
Alfaro JA, Ignatchenko A, Ignatchenko V, Sinha A, Boutros PC, Kislinger T. Detecting protein variants by mass spectrometry: a comprehensive study in cancer cell-lines. Genome Medicine. 9: 62. PMID 28716134 DOI: 10.1186/S13073-017-0454-9 |
0.413 |
|
| 2017 |
Jensen SR, Schoof EM, Wheeler SE, Hvid H, Ahnfelt-Rønne J, Hansen BF, Nishimura E, Olsen GS, Kislinger T, Brubaker PL. Quantitative proteomics of intestinal mucosa from male mice lacking intestinal epithelial insulin receptors. Endocrinology. PMID 28591806 DOI: 10.1210/En.2017-00194 |
0.318 |
|
| 2017 |
Sinha A, Alfaro J, Kislinger T. Characterization of Protein Content Present in Exosomes Isolated from Conditioned Media and Urine. Current Protocols in Protein Science. 87: 24.9.1-24.9.12. PMID 28150884 DOI: 10.1002/Cpps.23 |
0.382 |
|
| 2017 |
Seyfrid M, Chokshi C, Kuhlmann L, Venugopal C, Vora P, Sinha A, Ignatchenko V, Macklin A, Kislinger T, Singh S. Stem-17. Characterization Of The Cell Surface Proteome In Recurrent Glioblastoma Initiating Cells Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.933 |
0.313 |
|
| 2016 |
Wang D, Pham NA, Tong J, Sakashita S, Allo G, Kim L, Yanagawa N, Raghavan V, Wei Y, To C, Trinh QM, Starmans MH, Chan-Seng-Yue MA, Chadwick D, Li L, ... ... Kislinger T, et al. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors. International Journal of Cancer. PMID 27750381 DOI: 10.1002/Ijc.30472 |
0.337 |
|
| 2016 |
Kim Y, Jeon J, Mejia S, Yao CQ, Ignatchenko V, Nyalwidhe JO, Gramolini AO, Lance RS, Troyer DA, Drake RR, Boutros PC, Semmes OJ, Kislinger T. Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer. Nature Communications. 7: 11906. PMID 27350604 DOI: 10.1038/Ncomms11906 |
0.375 |
|
| 2016 |
Baker L, BeGora M, Au Yeung F, Feigin ME, Rosenberg AZ, Lowe SW, Kislinger T, Muthuswamy SK. SCRIBBLE is required for pregnancy-induced alveologenesis in the adult mammary gland. Journal of Cell Science. PMID 27179074 DOI: 10.1242/Dev.141093 |
0.32 |
|
| 2016 |
Neely BA, Wilkins CE, Marlow LA, Malyarenko D, Kim Y, Ignatchenko A, Sasinowska H, Sasinowski M, Nyalwidhe JO, Kislinger T, Copland JA, Drake RR. Proteotranscriptomic Analysis Reveals Stage Specific Changes in the Molecular Landscape of Clear-Cell Renal Cell Carcinoma. Plos One. 11: e0154074. PMID 27128972 DOI: 10.1371/Journal.Pone.0154074 |
0.399 |
|
| 2016 |
Nawaz M, Fatima F, Nazarenko I, Ekström K, Murtaza I, Anees M, Sultan A, Neder L, Camussi G, Valadi H, Squire JA, Kislinger T. Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery. Expert Review of Proteomics. 13: 395-409. PMID 26973172 DOI: 10.1586/14789450.2016.1165613 |
0.355 |
|
| 2016 |
Dimitrakopoulos L, Prassas I, Diamandis EP, Nesvizhskii A, Kislinger T, Jaffe J, Drabovich A. Proteogenomics: Opportunities and Caveats. Clinical Chemistry. 62: 551-7. PMID 26817480 DOI: 10.1373/Clinchem.2015.247858 |
0.351 |
|
| 2015 |
Sharma P, Abbasi C, Lazic S, Teng AC, Wang D, Dubois N, Ignatchenko V, Wong V, Liu J, Araki T, Tiburcy M, Ackerley C, Zimmermann WH, Hamilton R, Sun Y, ... ... Kislinger T, et al. Evolutionarily conserved intercalated disc protein Tmem65 regulates cardiac conduction and connexin 43 function. Nature Communications. 6: 8391. PMID 26403541 DOI: 10.1038/Ncomms9391 |
0.339 |
|
| 2015 |
Ghavidel A, Baxi K, Ignatchenko V, Prusinkiewicz M, Arnason TG, Kislinger T, Carvalho CE, Harkness TA. A Genome Scale Screen for Mutants with Delayed Exit from Mitosis: Ire1-Independent Induction of Autophagy Integrates ER Homeostasis into Mitotic Lifespan. Plos Genetics. 11: e1005429. PMID 26247883 DOI: 10.1371/Journal.Pgen.1005429 |
0.361 |
|
| 2015 |
Hao Y, Colak R, Teyra J, Corbi-Verge C, Ignatchenko A, Hahne H, Wilhelm M, Kuster B, Braun P, Kaida D, Kislinger T, Kim PM. Semi-supervised Learning Predicts Approximately One Third of the Alternative Splicing Isoforms as Functional Proteins. Cell Reports. PMID 26146086 DOI: 10.1016/J.Celrep.2015.06.031 |
0.335 |
|
| 2015 |
Wei Y, Vellanki RN, Coyaud É, Ignatchenko V, Li L, Krieger JR, Taylor P, Tong J, Pham NA, Liu G, Raught B, Wouters BG, Kislinger T, Tsao MS, Moran MF. CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell Migration. Molecular Cancer Research : McR. 13: 1119-29. PMID 25784717 DOI: 10.1158/1541-7786.Mcr-14-0165-T |
0.362 |
|
| 2015 |
Moran MF, Kislinger T, Li L, Ignatchenko V, Wei Y, To C, Taylor P, Tong J, Pham NA, Pintilie M, Muthuswamy L, Shepherd FA, Tsao MS. Abstract A2-49: Integrated Omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-A2-49 |
0.372 |
|
| 2015 |
Principe S, Ignatchenko V, Ignatchenko A, Sinha A, Pereira K, Ailles L, Kislinger T. Abstract B34: Signaling in the tumor microenvironment: Proteomics analyses of stromal-tumor interaction in oral cancers Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-B34 |
0.424 |
|
| 2015 |
Moran MF, Li L, Wei Y, Taylor P, To C, Tong J, Ignatchenko V, Pintilie M, Pham N, Zhang W, Muthuswamy L, Shepherd FA, Kislinger T, Tsao MS. Abstract SY33-04: Integrated omic analysis of lung cancer reveals metabolism-proteome signatures with prognostic impact Molecular and Cellular Biology. DOI: 10.1158/1538-7445.Am2015-Sy33-04 |
0.302 |
|
| 2015 |
Banh RS, Iorio C, Marcotte R, Xu Y, Cojocari D, Rahman AA, Pawling J, Sinha A, Hitomi T, Habu T, Koizumi A, Wilkins S, Kislinger T, Schofield CJ, Dennis JW, et al. Abstract LB-302: PTP1B regulates the Moyamoya disease-associated E3 ligase, RNF213 and cellular dioxygenase activity to allow breast tumor survival in hypoxia Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-302 |
0.334 |
|
| 2015 |
Zhang W, Taylor P, Li L, Wei Y, Tong J, Ignatchenko V, Pham N, Kislinger T, Tsao M, Moran M. Abstract 1822: Proteome signatures distinguish lung cancer subtypes, define metabolism states, and have prognostic impact Cancer Research. 75: 1822-1822. DOI: 10.1158/1538-7445.Am2015-1822 |
0.397 |
|
| 2014 |
Li L, Wei Y, To C, Zhu CQ, Tong J, Pham NA, Taylor P, Ignatchenko V, Ignatchenko A, Zhang W, Wang D, Yanagawa N, Li M, Pintilie M, Liu G, ... ... Kislinger T, et al. Integrated omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact. Nature Communications. 5: 5469. PMID 25429762 DOI: 10.1038/Ncomms6469 |
0.378 |
|
| 2014 |
Nawaz M, Camussi G, Valadi H, Nazarenko I, Ekström K, Wang X, Principe S, Shah N, Ashraf NM, Fatima F, Neder L, Kislinger T. The emerging role of extracellular vesicles as biomarkers for urogenital cancers. Nature Reviews. Urology. 11: 688-701. PMID 25403245 DOI: 10.1038/Nrurol.2014.301 |
0.339 |
|
| 2014 |
Alfaro JA, Sinha A, Kislinger T, Boutros PC. Onco-proteogenomics: cancer proteomics joins forces with genomics. Nature Methods. 11: 1107-13. PMID 25357240 DOI: 10.1038/Nmeth.3138 |
0.388 |
|
| 2014 |
Lu ZQ, Sinha A, Sharma P, Kislinger T, Gramolini AO. Proteomic analysis of human fetal atria and ventricle. Journal of Proteome Research. 13: 5869-78. PMID 25323733 DOI: 10.1021/Pr5007685 |
0.341 |
|
| 2014 |
Sepiashvili L, Waggott D, Hui A, Shi W, Su S, Ignatchenko A, Ignatchenko V, Laureano M, Huang SH, Xu W, Weinreb I, Waldron J, O'Sullivan B, Irish JC, Boutros PC, ... ... Kislinger T, et al. Integrated omic analysis of oropharyngeal carcinomas reveals human papillomavirus (HPV)-dependent regulation of the activator protein 1 (AP-1) pathway. Molecular & Cellular Proteomics : McP. 13: 3572-84. PMID 25271301 DOI: 10.1074/Mcp.M114.041764 |
0.345 |
|
| 2014 |
Shimoda M, Principe S, Jackson HW, Luga V, Fang H, Molyneux SD, Shao YW, Aiken A, Waterhouse PD, Karamboulas C, Hess FM, Ohtsuka T, Okada Y, Ailles L, Ludwig A, ... ... Kislinger T, et al. Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state. Nature Cell Biology. 16: 889-901. PMID 25150980 DOI: 10.1038/Ncb3021 |
0.376 |
|
| 2014 |
Klockenbusch C, Walsh GM, Brown LM, Hoffman MD, Ignatchenko V, Kislinger T, Kast J. Global proteome analysis identifies active immunoproteasome subunits in human platelets. Molecular & Cellular Proteomics : McP. 13: 3308-19. PMID 25146974 DOI: 10.1074/Mcp.M113.031757 |
0.307 |
|
| 2014 |
Drake RR, Kislinger T. The proteomics of prostate cancer exosomes. Expert Review of Proteomics. 11: 167-77. PMID 24564711 DOI: 10.1586/14789450.2014.890894 |
0.353 |
|
| 2014 |
Zhang W, Wei Y, Ignatchenko V, Li L, Sakashita S, Pham NA, Taylor P, Tsao MS, Kislinger T, Moran MF. Proteomic profiles of human lung adeno and squamous cell carcinoma using super-SILAC and label-free quantification approaches. Proteomics. 14: 795-803. PMID 24453208 DOI: 10.1002/Pmic.201300382 |
0.394 |
|
| 2014 |
Sinha A, Ignatchenko V, Ignatchenko A, Mejia-Guerrero S, Kislinger T. In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome. Biochemical and Biophysical Research Communications. 445: 694-701. PMID 24434149 DOI: 10.1016/J.Bbrc.2013.12.070 |
0.411 |
|
| 2013 |
Garnier D, Magnus N, Meehan B, Kislinger T, Rak J. Qualitative changes in the proteome of extracellular vesicles accompanying cancer cell transition to mesenchymal state. Experimental Cell Research. 319: 2747-57. PMID 23954818 DOI: 10.1016/J.Yexcr.2013.08.003 |
0.379 |
|
| 2013 |
Kim Y, Kislinger T. Novel approaches for the identification of biomarkers of aggressive prostate cancer. Genome Medicine. 5: 56. PMID 23809668 DOI: 10.1186/Gm460 |
0.382 |
|
| 2013 |
Principe S, Jones EE, Kim Y, Sinha A, Nyalwidhe JO, Brooks J, Semmes OJ, Troyer DA, Lance RS, Kislinger T, Drake RR. In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. Proteomics. 13: 1667-71. PMID 23533145 DOI: 10.1002/Pmic.201200561 |
0.351 |
|
| 2013 |
Principe S, Hui AB, Bruce J, Sinha A, Liu FF, Kislinger T. Tumor-derived exosomes and microvesicles in head and neck cancer: implications for tumor biology and biomarker discovery. Proteomics. 13: 1608-23. PMID 23505015 DOI: 10.1002/Pmic.201200533 |
0.377 |
|
| 2012 |
Garnier D, Magnus N, Lee TH, Bentley V, Meehan B, Milsom C, Montermini L, Kislinger T, Rak J. Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor. The Journal of Biological Chemistry. 287: 43565-72. PMID 23118232 DOI: 10.1074/Jbc.M112.401760 |
0.355 |
|
| 2012 |
Kim Y, Ignatchenko V, Yao CQ, Kalatskaya I, Nyalwidhe JO, Lance RS, Gramolini AO, Troyer DA, Stein LD, Boutros PC, Medin JA, Semmes OJ, Drake RR, Kislinger T. Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer. Molecular & Cellular Proteomics : McP. 11: 1870-84. PMID 22986220 DOI: 10.1074/Mcp.M112.017889 |
0.351 |
|
| 2012 |
Sepiashvili L, Hui A, Ignatchenko V, Shi W, Su S, Xu W, Huang SH, O'Sullivan B, Waldron J, Irish JC, Perez-Ordonez B, Liu FF, Kislinger T. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy. Molecular & Cellular Proteomics : McP. 11: 1404-15. PMID 22918226 DOI: 10.1074/Mcp.M112.020933 |
0.43 |
|
| 2012 |
Chugh S, Sharma P, Kislinger T, Gramolini AO. Clinical proteomics: getting to the heart of the matter. Circulation. Cardiovascular Genetics. 5: 377. PMID 22715282 DOI: 10.1161/Circgenetics.110.957761 |
0.39 |
|
| 2012 |
Bocchinfuso DG, Taylor P, Ross E, Ignatchenko A, Ignatchenko V, Kislinger T, Pearson BJ, Moran MF. Proteomic profiling of the planarian Schmidtea mediterranea and its mucous reveals similarities with human secretions and those predicted for parasitic flatworms. Molecular & Cellular Proteomics : McP. 11: 681-91. PMID 22653920 DOI: 10.1074/Mcp.M112.019026 |
0.403 |
|
| 2012 |
Rugg-Gunn PJ, Cox BJ, Lanner F, Sharma P, Ignatchenko V, McDonald AC, Garner J, Gramolini AO, Rossant J, Kislinger T. Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells. Developmental Cell. 22: 887-901. PMID 22424930 DOI: 10.1016/J.Devcel.2012.01.005 |
0.346 |
|
| 2012 |
Siddiqui NU, Li X, Luo H, Karaiskakis A, Hou H, Kislinger T, Westwood JT, Morris Q, Lipshitz HD. Genome-wide analysis of the maternal-to-zygotic transition in Drosophila primordial germ cells. Genome Biology. 13: R11. PMID 22348290 DOI: 10.1186/Gb-2012-13-2-R11 |
0.342 |
|
| 2012 |
Principe S, Kim Y, Fontana S, Ignatchenko V, Nyalwidhe JO, Lance RS, Troyer DA, Alessandro R, Semmes OJ, Kislinger T, Drake RR, Medin JA. Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine. Journal of Proteome Research. 11: 2386-96. PMID 22339264 DOI: 10.1021/Pr2011236 |
0.36 |
|
| 2012 |
Moran MF, To C, Wei Y, Li L, Taylor P, Ignatchenko V, Strumpf D, Tong J, Pham N, Jurisica I, Muthuswamy L, Kislinger T, Tsao M. Abstract 5127: Characterization of lung cancers by integrated genomic and proteomic analysis Cancer Research. 72: 5127-5127. DOI: 10.1158/1538-7445.Am2012-5127 |
0.379 |
|
| 2012 |
To C, Strumpf D, Panchal D, Li M, Pham N, Xie W, Yanagawa N, Bandarchi B, Chui MH, Der S, Shepherd FA, Kislinger T, Moran M, Jurisica I, Muthuswamy L, et al. Abstract 5069: Genomic profiles of primary non-small cell lung cancer (NSCLC) xenograft tumors identify distinct gene signatures associated with histological subtypes Cancer Research. 72: 5069-5069. DOI: 10.1158/1538-7445.Am2012-5069 |
0.366 |
|
| 2012 |
Wei Y, Taylor P, Tong J, Pham N, Li M, Panchal D, To C, Chui MH, Tsao M, Kislinger T, Moran MF. Abstract 4805: Distinctive phospho-proteome signatures in non-small cell lung carcinoma tumors Cancer Research. 72: 4805-4805. DOI: 10.1158/1538-7445.Am2012-4805 |
0.348 |
|
| 2011 |
Cox B, Sharma P, Evangelou AI, Whiteley K, Ignatchenko V, Ignatchenko A, Baczyk D, Czikk M, Kingdom J, Rossant J, Gramolini AO, Adamson SL, Kislinger T. Translational analysis of mouse and human placental protein and mRNA reveals distinct molecular pathologies in human preeclampsia. Molecular & Cellular Proteomics : McP. 10: M111.012526. PMID 21986993 DOI: 10.1074/Mcp.M111.012526 |
0.374 |
|
| 2011 |
Knobbe CB, Revett TJ, Bai Y, Chow V, Jeon AH, Böhm C, Ehsani S, Kislinger T, Mount HT, Mak TW, St George-Hyslop P, Schmitt-Ulms G. Choice of biological source material supersedes oxidative stress in its influence on DJ-1 in vivo interactions with Hsp90. Journal of Proteome Research. 10: 4388-404. PMID 21819105 DOI: 10.1021/Pr200225C |
0.341 |
|
| 2011 |
Kim Y, Elschenbroich S, Sharma P, Sepiashvili L, Gramolini AO, Kislinger T. Use of colloidal silica-beads for the isolation of cell-surface proteins for mass spectrometry-based proteomics. Methods in Molecular Biology (Clifton, N.J.). 748: 227-41. PMID 21701978 DOI: 10.1007/978-1-61779-139-0_16 |
0.343 |
|
| 2011 |
Dunham WH, Larsen B, Tate S, Badillo BG, Goudreault M, Tehami Y, Kislinger T, Gingras AC. A cost-benefit analysis of multidimensional fractionation of affinity purification-mass spectrometry samples. Proteomics. 11: 2603-12. PMID 21630450 DOI: 10.1002/Pmic.201000571 |
0.347 |
|
| 2011 |
Elschenbroich S, Ignatchenko V, Clarke B, Kalloger SE, Boutros PC, Gramolini AO, Shaw P, Jurisica I, Kislinger T. In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry. Journal of Proteome Research. 10: 2286-99. PMID 21491939 DOI: 10.1021/Pr1011087 |
0.425 |
|
| 2011 |
Ryan T, Sharma P, Ignatchenko A, MacLennan DH, Kislinger T, Gramolini AO. Identification of novel ryanodine receptor 1 (RyR1) protein interaction with calcium homeostasis endoplasmic reticulum protein (CHERP). The Journal of Biological Chemistry. 286: 17060-8. PMID 21454501 DOI: 10.1074/Jbc.M110.197186 |
0.353 |
|
| 2011 |
Sharma P, Shathasivam T, Ignatchenko V, Kislinger T, Gramolini AO. Identification of an FHL1 protein complex containing ACTN1, ACTN4, and PDLIM1 using affinity purifications and MS-based protein-protein interaction analysis. Molecular Biosystems. 7: 1185-96. PMID 21246116 DOI: 10.1039/C0Mb00235F |
0.37 |
|
| 2011 |
Elschenbroich S, Kislinger T. Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery. Molecular Biosystems. 7: 292-303. PMID 20976349 DOI: 10.1039/C0Mb00159G |
0.382 |
|
| 2011 |
Wei Y, Tong J, Taylor P, Strumpf D, Ignatchenko V, Pham NA, Yanagawa N, Liu G, Jurisica I, Shepherd FA, Tsao MS, Kislinger T, Moran MF. Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures. Journal of Proteome Research. 10: 161-74. PMID 20815376 DOI: 10.1021/Pr100491E |
0.369 |
|
| 2011 |
Jun SA, Sepiashvili L, Kislinger T, Minden MD. Investigating the Potential Use of L-Asparaginase in Myeloid Leukemia, Blood. 118: 3641-3641. DOI: 10.1182/Blood.V118.21.3641.3641 |
0.364 |
|
| 2011 |
Wei Y, Taylor P, Tong J, Strumpf D, Ignatchenko V, Pham NA, Thyparambil S, Tsao M, Kislinger T, Moran MF. Abstract 5097: Proteomic characterization of non-small cell lung cancer (NSCLC): Discovery and validation of NSCLC protein signatures and signaling networks Cancer Research. 71: 5097-5097. DOI: 10.1158/1538-7445.Am2011-5097 |
0.397 |
|
| 2010 |
Bousette N, Chugh S, Fong V, Isserlin R, Kim KH, Volchuk A, Backx PH, Liu P, Kislinger T, MacLennan DH, Emili A, Gramolini AO. Constitutively active calcineurin induces cardiac endoplasmic reticulum stress and protects against apoptosis that is mediated by alpha-crystallin-B. Proceedings of the National Academy of Sciences of the United States of America. 107: 18481-6. PMID 20937869 DOI: 10.1073/Pnas.1013555107 |
0.306 |
|
| 2010 |
Shathasivam T, Kislinger T, Gramolini AO. Genes, proteins and complexes: the multifaceted nature of FHL family proteins in diverse tissues. Journal of Cellular and Molecular Medicine. 14: 2702-20. PMID 20874719 DOI: 10.1111/J.1582-4934.2010.01176.X |
0.346 |
|
| 2010 |
Morozova O, Vojvodic M, Grinshtein N, Hansford LM, Blakely KM, Maslova A, Hirst M, Cezard T, Morin RD, Moore R, Smith KM, Miller F, Taylor P, Thiessen N, Varhol R, ... ... Kislinger T, et al. System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 4572-82. PMID 20651058 DOI: 10.1158/1078-0432.Ccr-10-0627 |
0.364 |
|
| 2010 |
Tiefenbach J, Moll PR, Nelson MR, Hu C, Baev L, Kislinger T, Krause HM. A live zebrafish-based screening system for human nuclear receptor ligand and cofactor discovery. Plos One. 5: e9797. PMID 20339547 DOI: 10.1371/Journal.Pone.0009797 |
0.303 |
|
| 2010 |
Drake RR, Elschenbroich S, Lopez-Perez O, Kim Y, Ignatchenko V, Ignatchenko A, Nyalwidhe JO, Basu G, Wilkins CE, Gjurich B, Lance RS, Semmes OJ, Medin JA, Kislinger T. In-depth proteomic analyses of direct expressed prostatic secretions. Journal of Proteome Research. 9: 2109-16. PMID 20334419 DOI: 10.1021/Pr1001498 |
0.371 |
|
| 2010 |
Elschenbroich S, Kim Y, Medin JA, Kislinger T. Isolation of cell surface proteins for mass spectrometry-based proteomics. Expert Review of Proteomics. 7: 141-54. PMID 20121483 DOI: 10.1586/Epr.09.97 |
0.369 |
|
| 2009 |
Symes J, Evangelou A, Ignatchenko A, Fleshner N, Kislinger T, Medin JA. Multidimensional protein identification technology analysis highlights mitoxantrone-induced expression modulations in the primary prostate cancer cell proteome. Proteomics. Clinical Applications. 3: 347-58. PMID 26238752 DOI: 10.1002/Prca.200800102 |
0.387 |
|
| 2009 |
Shi T, Weerasekera R, Yan C, Reginold W, Ball H, Kislinger T, Schmitt-Ulms G. Method for the affinity purification of covalently linked peptides following cyanogen bromide cleavage of proteins. Analytical Chemistry. 81: 9885-95. PMID 19924875 DOI: 10.1021/Ac901373Q |
0.314 |
|
| 2009 |
Bousette N, Kislinger T, Fong V, Isserlin R, Hewel JA, Emil A, Gramolini AO. Large-scale characterization and analysis of the murine cardiac proteome. Journal of Proteome Research. 8: 1887-901. PMID 19714876 DOI: 10.1021/Pr800845A |
0.401 |
|
| 2009 |
Elschenbroich S, Ignatchenko V, Sharma P, Schmitt-Ulms G, Gramolini AO, Kislinger T. Peptide separations by on-line MudPIT compared to isoelectric focusing in an off-gel format: application to a membrane-enriched fraction from C2C12 mouse skeletal muscle cells. Journal of Proteome Research. 8: 4860-9. PMID 19670906 DOI: 10.1021/Pr900318K |
0.316 |
|
| 2009 |
Cox B, Kotlyar M, Evangelou AI, Ignatchenko V, Ignatchenko A, Whiteley K, Jurisica I, Adamson SL, Rossant J, Kislinger T. Comparative systems biology of human and mouse as a tool to guide the modeling of human placental pathology. Molecular Systems Biology. 5: 279. PMID 19536202 DOI: 10.1038/Msb.2009.37 |
0.33 |
|
| 2009 |
Schmidt A, Bisle B, Kislinger T. Quantitative peptide and protein profiling by mass spectrometry. Methods in Molecular Biology (Clifton, N.J.). 492: 21-38. PMID 19241025 DOI: 10.1007/978-1-59745-493-3_2 |
0.416 |
|
| 2009 |
Taylor P, Nielsen PA, Trelle MB, Hørning OB, Andersen MB, Vorm O, Moran MF, Kislinger T. Automated 2D peptide separation on a 1D nano-LC-MS system. Journal of Proteome Research. 8: 1610-6. PMID 19178303 DOI: 10.1021/Pr800986C |
0.346 |
|
| 2008 |
Bousette N, Gramolini AO, Kislinger T. Proteomics-based investigations of animal models of disease. Proteomics. Clinical Applications. 2: 638-53. PMID 21136864 DOI: 10.1002/Prca.200780043 |
0.394 |
|
| 2008 |
Jurisicova A, Jurisica I, Kislinger T. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions. Expert Review of Proteomics. 5: 551-60. PMID 18761466 DOI: 10.1586/14789450.5.4.551 |
0.379 |
|
| 2008 |
Sodek KL, Evangelou AI, Ignatchenko A, Agochiya M, Brown TJ, Ringuette MJ, Jurisica I, Kislinger T. Identification of pathways associated with invasive behavior by ovarian cancer cells using multidimensional protein identification technology (MudPIT). Molecular Biosystems. 4: 762-73. PMID 18563251 DOI: 10.1039/B717542F |
0.434 |
|
| 2008 |
Gramolini AO, Peterman SM, Kislinger T. Mass spectrometry-based proteomics: a useful tool for biomarker discovery? Clinical Pharmacology and Therapeutics. 83: 758-60. PMID 18388886 DOI: 10.1038/Clpt.2008.18 |
0.341 |
|
| 2008 |
Gortzak-Uzan L, Ignatchenko A, Evangelou AI, Agochiya M, Brown KA, St Onge P, Kireeva I, Schmitt-Ulms G, Brown TJ, Murphy J, Rosen B, Shaw P, Jurisica I, Kislinger T. A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers. Journal of Proteome Research. 7: 339-51. PMID 18076136 DOI: 10.1021/Pr0703223 |
0.406 |
|
| 2008 |
Gramolini AO, Kislinger T, Alikhani-Koopaei R, Fong V, Thompson NJ, Isserlin R, Sharma P, Oudit GY, Trivieri MG, Fagan A, Kannan A, Higgins DG, Huedig H, Hess G, Arab S, et al. Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses. Molecular & Cellular Proteomics : McP. 7: 519-33. PMID 18056057 DOI: 10.1074/Mcp.M700245-Mcp200 |
0.371 |
|
| 2007 |
Ghavidel A, Kislinger T, Pogoutse O, Sopko R, Jurisica I, Emili A. Impaired tRNA nuclear export links DNA damage and cell-cycle checkpoint. Cell. 131: 915-26. PMID 18045534 DOI: 10.1016/J.Cell.2007.09.042 |
0.311 |
|
| 2007 |
Weerasekera R, She YM, Markham KA, Bai Y, Opalka N, Orlicky S, Sicheri F, Kislinger T, Schmitt-Ulms G. Interactome and interface protocol (2IP): a novel strategy for high sensitivity topology mapping of protein complexes. Proteomics. 7: 3835-52. PMID 17960736 DOI: 10.1002/Pmic.200700688 |
0.341 |
|
| 2007 |
Cox B, Kislinger T, Wigle DA, Kannan A, Brown K, Okubo T, Hogan B, Jurisica I, Frey B, Rossant J, Emili A. Integrated proteomic and transcriptomic profiling of mouse lung development and Nmyc target genes. Molecular Systems Biology. 3: 109. PMID 17486137 DOI: 10.1038/Msb4100151 |
0.336 |
|
| 2007 |
Evangelou A, Gortzak-Uzan L, Jurisica I, Kislinger T. Mass spectrometry, proteomics, data mining strategies and their applications in infectious disease research Anti-Infective Agents in Medicinal Chemistry. 6: 89-105. DOI: 10.2174/187152107780361689 |
0.368 |
|
| 2006 |
Arab S, Gramolini AO, Ping P, Kislinger T, Stanley B, van Eyk J, Ouzounian M, MacLennan DH, Emili A, Liu PP. Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. Journal of the American College of Cardiology. 48: 1733-41. PMID 17084242 DOI: 10.1016/J.Jacc.2006.06.063 |
0.396 |
|
| 2006 |
Kislinger T, Cox B, Kannan A, Chung C, Hu P, Ignatchenko A, Scott MS, Gramolini AO, Morris Q, Hallett MT, Rossant J, Hughes TR, Frey B, Emili A. Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling. Cell. 125: 173-86. PMID 16615898 DOI: 10.1016/J.Cell.2006.01.044 |
0.365 |
|
| 2005 |
Kislinger T, Humeny A, Peich CC, Becker CM, Pischetsrieder M. Analysis of protein glycation products by MALDI-TOF/MS. Annals of the New York Academy of Sciences. 1043: 249-59. PMID 16037245 DOI: 10.1196/Annals.1333.030 |
0.305 |
|
| 2005 |
Kislinger T, Gramolini AO, MacLennan DH, Emili A. Multidimensional protein identification technology (MudPIT): technical overview of a profiling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue. Journal of the American Society For Mass Spectrometry. 16: 1207-20. PMID 15979338 DOI: 10.1016/J.Jasms.2005.02.015 |
0.368 |
|
| 2005 |
Kislinger T, Emili A. Multidimensional protein identification technology: current status and future prospects Expert Review of Proteomics. 2: 27-39. PMID 15966850 DOI: 10.1586/14789450.2.1.27 |
0.379 |
|
| 2005 |
Sandhu C, Connor M, Kislinger T, Slingerland J, Emili A. Global protein shotgun expression profiling of proliferating mcf-7 breast cancer cells. Journal of Proteome Research. 4: 674-89. PMID 15952714 DOI: 10.1021/Pr0498842 |
0.376 |
|
| 2005 |
Kislinger T, Gramolini AO, Pan Y, Rahman K, MacLennan DH, Emili A. Proteome dynamics during C2C12 myoblast differentiation. Molecular & Cellular Proteomics : McP. 4: 887-901. PMID 15824125 DOI: 10.1074/Mcp.M400182-Mcp200 |
0.349 |
|
| 2005 |
Cox B, Kislinger T, Emili A. Integrating gene and protein expression data: pattern analysis and profile mining. Methods. 35: 303-314. PMID 15722226 DOI: 10.1016/J.Ymeth.2004.08.021 |
0.374 |
|
| 2004 |
Kislinger T, Humeny A, Pischetsrieder M. Analysis of Protein Glycation Products by Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry Current Medicinal Chemistry. 11: 2185-2193. PMID 15279557 DOI: 10.2174/0929867043364649 |
0.348 |
|
| 2004 |
Pan Y, Kislinger T, Gramolini AO, Zvaritch E, Kranias EG, MacLennan DH, Emili A. Identification of biochemical adaptations in hyper- or hypocontractile hearts from phospholamban mutant mice by expression proteomics. Proceedings of the National Academy of Sciences of the United States of America. 101: 2241-6. PMID 14982994 DOI: 10.1073/Pnas.0308174101 |
0.349 |
|
| 2004 |
Coppinger JA, Cagney G, Toomey S, Kislinger T, Belton O, McRedmond JP, Cahill DJ, Emili A, Fitzgerald DJ, Maguire PB. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood. 103: 2096-104. PMID 14630798 DOI: 10.1182/Blood-2003-08-2804 |
0.322 |
|
| 2004 |
Kislinger T, Emili A. Going global: protein expression profiling using shotgun mass spectrometry. Current Opinion in Molecular Therapeutics. 5: 285-93. PMID 12870439 |
0.309 |
|
| 2004 |
Kislinger T, Cox B, Emili A. PRISM: a new strategy to analyze the mammalian proteome Drug Discovery Today: Targets. 3: 37-42. DOI: 10.1016/S1741-8372(04)02422-3 |
0.363 |
|
| 2003 |
Kislinger T, Rahman K, Radulovic D, Cox B, Rossant J, Emili A. PRISM, a generic large scale proteomic investigation strategy for mammals Molecular & Cellular Proteomics : McP. 2: 96-106. PMID 12644571 DOI: 10.1074/Mcp.M200074-Mcp200 |
0.412 |
|
| 2002 |
Humeny A, Kislinger T, Becker CM, Pischetsrieder M. Qualitative determination of specific protein glycation products by matrix-assisted laser desorption/ionization mass spectrometry Peptide mapping. Journal of Agricultural and Food Chemistry. 50: 2153-60. PMID 11902972 DOI: 10.1021/Jf011349O |
0.3 |
|
| Show low-probability matches. |